3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
22
Triple Negative Breast Neoplasms
9
Lung Neoplasms
8
Neoplasm Metastasis
7
Carcinoma, Non-Small-Cell Lung
7
Breast Neoplasms
7
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Head and Neck Neoplasms
3
Colorectal Neoplasms
3
Sarcoma
2
Recurrence
2
Rectal Neoplasms
2
Gallbladder Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Pancreatic Ductal
2
Biliary Tract Neoplasms
2
Adenocarcinoma
2
Uterine Cervical Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Resectable Pancreatic Cancer
1
Pancreatic Adenocarcinoma
1
Osteosarcoma
1
Non-Small Cell Lung Cancer Metastatic
1
Non Small Cell Lung Cancer NSCLC
1
Neoplasms, Basal Cell
1
Interventions
tislelizumab
3
Injections
2
Carboplatin
2
tumor-cells apoptosis factor, human
1
toripalimab
1
tazemetostat
1
sintilimab
1
pembrolizumab
1
osimertinib
1
enzalutamide
1
envafolimab
1
cemiplimab
1
WW Domain-Containing Oxidoreductase
1
Ultrasonography, Doppler
1
Ultrasonography
1
Radiotherapy
1
Proton Therapy
1
Oxaliplatin
1
Off-Label Use
1
Leucovorin
1
Indocyanine Green
1
Immune Checkpoint Inhibitors
1
Histocompatibility Testing
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
Doxorubicin
1
Cisplatin
1
Blood Specimen Collection
1
Bevacizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumor
×
Albumin-Bound Paclitaxel
×
90 days
×
Clear all
No trials found.